| P2093 | author name string | Samuel B Kombian | |
| | Subramanian S Parvathy | |
| | Kethireddy V V Ananthalakshmi | |
| | Wandikayi C Matowe | |
| P2860 | cites work | Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons | Q28143514 |
| | Cellular and molecular mechanisms of drug dependence | Q28283898 |
| | Distinct cholecystokinin receptors in brain and pancreas | Q28366068 |
| | The synaptic framework for chemical signaling in nucleus accumbens | Q33692754 |
| | Linked polymorphisms (-333G>T and -286A>G) in the promoter region of the CCK-A receptor gene may be associated with schizophrenia | Q34090616 |
| | Neuropeptides involved in the pathophysiology of schizophrenia and major depression | Q35130197 |
| | On the significance of subterritories in the "accumbens" part of the rat ventral striatum | Q35536722 |
| | The dopamine hypothesis of the reinforcing properties of cocaine | Q36695787 |
| | The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. | Q36724640 |
| | Cholecystokinin-dopamine interactions | Q37756133 |
| | Short-term synaptic plasticity | Q38613257 |
| | The functional output of the mesolimbic dopamine system | Q39548090 |
| | Cholecystokinin, dopamine, and schizophrenia: recent progress and current problems | Q39548142 |
| | Modulation of mesolimbic dopaminergic behaviors by cholecystokinin | Q39548147 |
| | Cellular localization of peptides in neural structures. | Q40098890 |
| | Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors | Q40624974 |
| | Cholecystokinin octapeptides alter the release of endogenous dopamine from the rat nucleus accumbens in vitro | Q41493641 |
| | Interactions of cholecystokinin and dopamine in the nucleus accumbens | Q41879525 |
| | Specificity in the efferent projections of the nucleus accumbens in the rat: comparison of the rostral pole projection patterns with those of the core and shell | Q42509706 |
| | Psychostimulants depress excitatory synaptic transmission in the nucleus accumbens via presynaptic D1-like dopamine receptors | Q42554516 |
| | Forebrain projections from cholecystokininlike-immunoreactive neurons in the rat midbrain | Q43433340 |
| | Dopamine depresses excitatory and inhibitory synaptic transmission by distinct mechanisms in the nucleus accumbens | Q43470331 |
| | Association studies of the CT repeat polymorphism in the 5' upstream region of the cholecystokinin B receptor gene with panic disorder and schizophrenia in Japanese subjects | Q43861876 |
| | Depression of excitatory cortico-nucleus accumbens synaptic transmission in rat brain slices by dopamine, but not adenosine, depends upon intracortical mechanisms | Q43865778 |
| | Differential effects of the CCKA receptor ligands PD-140,548 and A-71623 on latent inhibition in the rat. | Q43986061 |
| | Baclofen and adenosine inhibit synaptic potentials mediated by gamma-aminobutyric acid and glutamate release in rat nucleus accumbens | Q44304949 |
| | Substance P depresses excitatory synaptic transmission in the nucleus accumbens through dopaminergic and purinergic mechanisms | Q44306982 |
| | Dopamine and adenosine mediate substance P-induced depression of evoked IPSCs in the rat nucleus accumbens in vitro | Q44530060 |
| | Simultaneous LTP of non-NMDA- and LTD of NMDA-receptor-mediated responses in the nucleus accumbens | Q46076587 |
| | Modulation of synaptic transmission and long-term potentiation: effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus | Q46152163 |
| | Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis | Q46532827 |
| | The modulation of sensorimotor gating deficits by mesolimbic cholecystokinin | Q46623501 |
| | Striatal lesions and transplants demonstrate that cholecystokinin receptors are localized on intrinsic striatal neurones: a quantitative autoradiographic study | Q48227676 |
| | In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens | Q48277095 |
| | Physiological and morphological properties of accumbens core and shell neurons recorded in vitro | Q48336965 |
| | Two brain cholecystokinin receptors: implications for behavioral actions | Q48417682 |
| | Cholecystokinergic innervation of nucleus accumbens subregions | Q48431711 |
| | Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway | Q48433757 |
| | Presynaptic dopamine D1 receptors attenuate excitatory and inhibitory limbic inputs to the shell region of the rat nucleus accumbens studied in vitro | Q48486819 |
| | Cholecystokinin tunes firing of an electrically distinct subset of arcuate nucleus neurons by activating A-Type potassium channels. | Q48526059 |
| | Cholecystokinin innervation of the ventral striatum: a morphological and radioimmunological study | Q48529028 |
| | Autoradiographic Localization of Cholecystokinin A and B Receptors in Rat Brain Using [125I]d-Tyr25 (Nle28,31)-CCK 25 - 33S. | Q48551854 |
| | Distinct properties of cholecystokinin-8 and mixed dopamine-cholecystokinin-8 neurons innervating the nucleus accumbens | Q48570503 |
| | The distribution and some connections of cholecystokinin neurons in the rat brain | Q48570571 |
| | Cholecystokinin receptors in mammalian brain. A comparative characterization and visualization | Q48578208 |
| | Microinjections of nanogram amounts of sulfated cholecystokinin octapeptide into the rat nucleus accumbens attenuates brain stimulation reward | Q48600882 |
| | Modulation of excitatory synaptic transmission by drugs that reduce desensitization at AMPA/kainate receptors | Q48610528 |
| | Reduction of [125I]Bolton Hunter CCK8 and [3H]MK-329 (devazepide) binding to CCK receptors in the substantia nigra/VTA complex and its forebrain projection areas following MPTP-induced hemi-parkinsonism in the monkey | Q48653018 |
| | A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. | Q48658263 |
| | Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons | Q48668517 |
| | Quinazolinone cholecystokinin-B receptor ligands | Q48747050 |
| | Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms | Q48784606 |
| | CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens | Q48918859 |
| | Evidence for a differential cholecystokinin-B and -A receptor regulation of GABA release in the rat nucleus accumbens mediated via dopaminergic and cholinergic mechanisms | Q48954865 |
| | Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptors activation | Q49034284 |
| | Possible association of a cholecystokinin promoter variant to schizophrenia. | Q51955321 |
| | PD-135,158, a cholecystokinin(B) antagonist, enhances latent inhibition in the rat. | Q52170801 |
| | Pharmacological and mechanistic studies of cholecystokinin-facilitated [3H]dopamine efflux from rat nucleus accumbens | Q69056240 |
| | Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand | Q70202430 |
| | CCK nerve terminals in the rat striatal and limbic areas originate partly in the brain stem and partly in telencephalic structures | Q70428894 |
| | The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat | Q71335176 |
| | Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease | Q72222113 |
| | Phosphinic acid derivatives as baclofen agonists and antagonists in the mammalian spinal cord: an in vivo study | Q72508715 |
| | CGP 55845A: a potent antagonist of GABAB receptors in the CA1 region of rat hippocampus | Q72744072 |
| | Direct visualization of cholecystokinin subtype2 receptors in rat central nervous system using anti-peptide antibodies | Q73088582 |
| | Two neuropeptides recruit different messenger pathways to evoke Ca2+ signals in the same cell | Q74310906 |
| | Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry | Q74515942 |
| | Opposite effects of cholecystokinin octapeptide (CCK-8) and tetrapeptide (CCK-4) after injection into the caudal part of the nucleus accumbens or into its rostral part and the cerebral ventricles | Q84298254 |
| | Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anaesthetized rat | Q84298266 |
| | Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function | Q95784562 |
| P433 | issue | Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nucleus accumbens | Q1476178 |
| | cholecystokinin | Q60315441 |
| P1104 | number of pages | 14 | |
| P304 | page(s) | 71-84 | |
| P577 | publication date | 2003-12-12 | |
| P1433 | published in | Journal of Physiology | Q7743612 |
| P1476 | title | Cholecystokinin activates CCKB receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro | |
| P478 | volume | 555 | |